Zacks Research Brokers Boost Earnings Estimates for Revvity

Posted by George Bondi on Jun 30th, 2026

Revvity Inc. (NYSE:RVTY – Free Report) – Investment analysts at Zacks Research upped their Q2 2026 earnings per share (EPS) estimates for shares of Revvity in a report released on Thursday, June 25th. Zacks Research analyst Team now forecasts that the company will post earnings of $1.22 per share for the quarter, up from their prior forecast of $1.21. The consensus estimate for Revvity’s current full-year earnings is $5.25 per share. Zacks Research also issued estimates for Revvity’s Q4 2026 earnings at $1.67 EPS, FY2026 earnings at $5.25 EPS, Q2 2027 earnings at $1.44 EPS, Q4 2027 earnings at $1.74 EPS, Q1 2028 earnings at $1.36 EPS and FY2028 earnings at $6.58 EPS.

Revvity (NYSE:RVTY – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. The business had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The business’s revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS.

A number of other research analysts also recently issued reports on the company. The Goldman Sachs Group cut their price target on Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a report on Tuesday, April 14th. Robert W. Baird set a $117.00 target price on Revvity in a research note on Wednesday, May 6th. Wolfe Research began coverage on shares of Revvity in a report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. TD Cowen raised their price target on shares of Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Finally, Barclays lifted their price objective on shares of Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Four research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $108.33.

Read Our Latest Analysis on Revvity

Revvity Stock Down 1.7%

Shares of Revvity stock opened at $111.12 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. The stock has a market cap of $12.40 billion, a price-to-earnings ratio of 53.17, a PEG ratio of 2.47 and a beta of 1.11. The firm’s 50-day moving average is $97.89 and its two-hundred day moving average is $97.82. Revvity has a 1 year low of $81.22 and a 1 year high of $118.30.

Institutional Investors Weigh In On Revvity

A number of large investors have recently bought and sold shares of the company. Byrne Asset Management LLC lifted its stake in shares of Revvity by 0.9% in the fourth quarter. Byrne Asset Management LLC now owns 11,138 shares of the company’s stock worth $1,078,000 after buying an additional 100 shares in the last quarter. New Mexico Educational Retirement Board raised its holdings in Revvity by 1.9% in the 4th quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock valued at $524,000 after acquiring an additional 100 shares during the last quarter. Allworth Financial LP lifted its stake in Revvity by 8.9% in the 4th quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock worth $123,000 after purchasing an additional 104 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Revvity by 17.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock worth $66,000 after purchasing an additional 109 shares in the last quarter. Finally, Trust Point Inc. lifted its stake in Revvity by 3.8% in the 4th quarter. Trust Point Inc. now owns 3,215 shares of the company’s stock worth $311,000 after purchasing an additional 117 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s dividend payout ratio (DPR) is presently 13.40%.

Revvity Company Profile

(Get Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Earnings History and Estimates for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.